Literature DB >> 7228447

Physostigmine salicylate as an antidote.

M Daunderer.   

Abstract

Most poisonings with anticholinergics deal with simple cases without diagnostic or therapeutic difficulties; however, in difficult or unclarified cases a new method for diagnosis and treatment is the antidote physostigmine salicylate. Within 15 minutes after application of 2 mg of the antidote the central anticholinergic symptoms disappear, such as respiratory depression, coma, cramps and hallucinations as do the peripheral anticholinergic symptoms as cardiac rhythm disturbance, dry mouth and red dry skin. No fatal overdose with anticholinergic drugs occurs if the antidote is given in time.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7228447

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  4 in total

Review 1.  Clinical pharmacokinetics of cholinesterase inhibitors.

Authors:  S M Aquilonius; P Hartvig
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

2.  Psychosis due to transdermally administered scopolamine.

Authors:  G W MacEwan; R A Remick; J A Noone
Journal:  CMAJ       Date:  1985-09-01       Impact factor: 8.262

3.  Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat.

Authors:  M Hallak; E Giacobini
Journal:  Neurochem Res       Date:  1986-07       Impact factor: 3.996

4.  Urinary pharmacokinetics of physostigmine in the rat.

Authors:  S M Somani; A Boyer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.